Park Place Capital Corp

Position in GILD — Gilead Sciences, Inc.

CIK 1965810 Homewood, AL

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$88,058

-$2,393 QoQ

Shares Held

697

+7.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#2,007

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Healthcare · as of Jun 30, 2026

Park Place Capital Corp holds $11,539,581 across 14 Drug Manufacturers - General names. GILD ranks #10 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	14,307	$3,600,212
2	BMY	Bristol Myers Squibb Co	61,611	$3,550,025
3	LLY	ELI LILLY & Co	806	$966,740
4	MRK	Merck & Co., Inc.	6,461	$830,237
5	PFE	Pfizer Inc	30,792	$741,471
6	SNY	Sanofi	13,474	$574,800
7	JNJ	Johnson & Johnson	2,250	$571,432
8	AMGN	Amgen Inc	1,208	$437,440

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$88,058	697	+7.4%	Shares	Sole	2026-08-14
2026-03-31	$90,451	649	-70.4%	Shares	Sole	2026-04-09
2025-12-31	$268,800	2,190	-19.6%	Shares	Sole	2026-01-09
2025-09-30	$302,364	2,724	-20.9%	Shares	Sole	2025-10-22
2025-06-30	$381,947	3,445	-37.7%	Shares	Sole	2025-07-17
2025-03-31	$619,524	5,529	-20.3%	Shares	Sole	2025-04-24
2024-12-31	$641,140	6,941	-17.7%	Shares	Sole	2025-01-17
2024-09-30	$706,855	8,431	+25.3%	Shares	Sole	2024-10-08
2024-06-30	$461,470	6,726	-16.9%	Shares	Sole	2024-07-02
2024-03-31	$593,032	8,096	+19.4%	Shares	Sole	2024-04-18
2023-12-31	$549,409	6,782	-21.1%	Shares	Sole	2024-01-24
2023-09-30	$644,184	8,596	-45.5%	Shares	Sole	2023-10-17
2023-06-30	$1,215,085	15,766	-27.2%	Shares	Sole	2023-08-04
2023-03-31	$1,797,876	21,669	-25.1%	Shares	Sole	2023-05-02
2022-12-31	$2,482,782	28,920	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.